Almirall, S.A. (ALMRY)
OTCMKTS · Delayed Price · Currency is USD
12.76
+1.25 (10.91%)
At close: Aug 13, 2025
Almirall Revenue
Almirall had revenue of 262.23M EUR in the quarter ending September 30, 2025, with 13.46% growth. This brings the company's revenue in the last twelve months to 1.09B, up 13.80% year-over-year. In the year 2024, Almirall had annual revenue of 990.63M with 10.22% growth.
Revenue (ttm)
1.09B EUR
Revenue Growth
+13.80%
P/S Ratio
2.71
Revenue / Employee
520.65K EUR
Employees
2,084
Market Cap
3.46B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 990.63M | 91.84M | 10.22% |
| Dec 31, 2023 | 898.79M | 20.28M | 2.31% |
| Dec 31, 2022 | 878.51M | 42.01M | 5.02% |
| Dec 31, 2021 | 836.50M | 22.01M | 2.70% |
| Dec 31, 2020 | 814.49M | -96.17M | -10.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sofgen Pharma | 423.75M |
| Jushi Holdings | 260.43M |
| Glass House Brands | 196.17M |
| MariMed | 157.38M |
| Elite Pharmaceuticals | 122.89M |
| Earth Science Tech | 33.84M |
| Radnostix | 14.07M |
| Healthy Extracts | 3.59M |
Almirall News
- 23 days ago - Almirall, S.A. (LBTSF) Presents at 44th Annual J.P. - Seeking Alpha
- 4 weeks ago - Almirall Announces "LumiNE", a Phase III Clinical Study Assessing the Efficacy of Lebrikizumab for the Treatment of Nummular Eczema - Benzinga
- 3 months ago - Almirall, S.A. (LBTSF) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Almirall SA (FRA:E2Z) Q3 2025 Earnings Call Highlights: Strong Sales Growth and Strategic ... - GuruFocus
- 3 months ago - Q3 2025 Almirall SA Earnings Call Transcript - GuruFocus
- 3 months ago - Almirall, S.A. 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 7 months ago - Almirall, S.A. 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 7 months ago - Almiralll, S.A. (LBTSF) Q2 2025 Earnings Call Transcript - Seeking Alpha